MarketCap
Facebook
X
TelegramQuarterly report 2022-Q4
added 02-09-2023
Quotient Limited Current Ratio 2011-2025 | QTNT
Annual Current Ratio Quotient Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.861 | 4.83 | 4.59 | 1.92 | 1.37 | 2.89 | 0.914 | 1.5 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.83 | 0.861 | 2.36 |
Quarterly Current Ratio Quotient Limited
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.36 | 0.41 | 0.54 | 0.57 | 0.62 | 0.75 | 0.82 | 0.84 | 1.01 | 1.03 | 1.14 | 0.87 | 1.08 | 0.79 | 0.9 | 1.01 | 1.15 | 0.91 | 0.78 | 0.89 | 1.03 | 0.88 | 1.03 | 0.82 | 0.96 | 1.37 | 1.38 | 1.64 | 1.41 | 1.13 | 0.9 | 0.98 | 0.89 | 1.26 | 1.67 | 0.97 | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.67 | 0.36 | 0.966 |
Current Ratio of other stocks in the Diagnostics research industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Brainsway Ltd.
BWAY
|
2.37 | $ 16.87 | 0.12 % | $ 99.4 M |  Israel |
 |
Centogene N.V.
CNTG
|
2.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
DarioHealth Corp.
DRIO
|
4.85 | $ 11.98 | 0.76 % | $ 340 M | Israel |
|
Akumin
AKU
|
1.09 | - | -17.87 % | $ 25.9 M |  Canada |
 |
DexCom
DXCM
|
1.49 | $ 65.83 | -1.69 % | $ 25.4 B |  USA |
 |
Burning Rock Biotech Limited
BNR
|
5.26 | $ 16.48 | 4.6 % | $ 177 M |  China |
 |
Exact Sciences Corporation
EXAS
|
1.68 | $ 101.53 | 0.02 % | $ 18.8 B | USA |
 |
Accelerate Diagnostics
AXDX
|
0.745 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
1.4 | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
1.86 | $ 1.57 | -3.4 % | $ 2 M | USA |
 |
IQVIA Holdings
IQV
|
1.29 | $ 221.78 | -0.22 % | $ 40.2 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
15.6 | - | - | $ 562 M |  Britain |
 |
Castle Biosciences
CSTL
|
7.05 | $ 38.58 | -0.13 % | $ 1.07 B | USA |
 |
Chembio Diagnostics
CEMI
|
1.4 | - | 0.22 % | $ 16.8 M | USA |
 |
Danaher Corporation
DHR
|
5.19 | $ 226.12 | -0.09 % | $ 165 B | USA |
 |
Fulgent Genetics
FLGT
|
13.4 | $ 26.93 | -0.77 % | $ 814 M | USA |
 |
Global Cord Blood Corporation
CO
|
2.34 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
2.17 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
4.76 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
2.28 | - | 0.12 % | $ 80.1 M | China |
 |
NeoGenomics
NEO
|
2.23 | $ 11.99 | 1.18 % | $ 1.52 B | USA |
 |
Neogen Corporation
NEOG
|
2.51 | $ 6.76 | -1.46 % | $ 1.47 B | USA |
 |
DermTech
DMTK
|
1.88 | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.15 | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
2.27 | $ 19.76 | -3.89 % | $ 1.06 B | USA |
 |
Celcuity
CELC
|
1.89 | $ 102.06 | -3.03 % | $ 4.03 B | USA |
 |
Pacific Biosciences of California
PACB
|
1.67 | $ 2.1 | -1.18 % | $ 533 M | USA |
 |
Enzo Biochem
ENZ
|
2.89 | - | -8.98 % | $ 14.8 K | USA |
 |
Anixa Biosciences
ANIX
|
7.99 | $ 3.3 | -7.82 % | $ 105 K | USA |
 |
Co-Diagnostics
CODX
|
10.2 | $ 0.31 | -9.72 % | $ 9.1 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
1.71 | $ 26.46 | -0.6 % | $ 20 B |  Niderland |
 |
Precipio
PRPO
|
4.93 | $ 24.67 | -1.2 % | $ 32 M | USA |
 |
Quidel Corporation
QDEL
|
3.39 | $ 28.44 | -1.25 % | $ 1.2 B | USA |
 |
QIAGEN N.V.
QGEN
|
1.88 | $ 45.02 | -0.44 % | $ 10 B | Niderland |
 |
Guardant Health
GH
|
0.914 | $ 103.45 | 1.35 % | $ 12.7 B | USA |
 |
Aspira Women's Health
AWH
|
1.63 | - | -6.19 % | $ 10.5 M | USA |
 |
Sotera Health Company
SHC
|
1.15 | $ 16.82 | -0.09 % | $ 4.76 B | USA |
 |
Soleno Therapeutics
SLNO
|
3.85 | $ 50.26 | -3.36 % | $ 2.02 B | USA |
 |
Heska Corporation
HSKA
|
3.58 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
1.44 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
6.69 | $ 134.16 | -0.52 % | $ 21.3 B | USA |
 |
Charles River Laboratories International
CRL
|
1.87 | $ 196.68 | 1.89 % | $ 10.1 B | USA |
 |
Thermo Fisher Scientific
TMO
|
1.92 | $ 571.15 | -0.12 % | $ 218 B | USA |
 |
Trinity Biotech plc
TRIB
|
0.746 | $ 0.99 | -7.5 % | $ 61.9 M |  Irlanda |
 |
Twist Bioscience Corporation
TWST
|
3.8 | $ 30.97 | 0.11 % | $ 1.85 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.25 | $ 183.34 | 0.43 % | $ 20.4 B | USA |
|
Biodesix
BDSX
|
1.27 | $ 7.63 | -2.8 % | $ 989 M | USA |
 |
Mettler-Toledo International
MTD
|
0.962 | $ 1 405.44 | 0.85 % | $ 29.8 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
3.15 | $ 6.93 | -3.88 % | $ 628 M | USA |